CCL5 is secreted by certain types of tumor cells [21], and clinical studies show that elevated levels of CCL5 in tissues and plasma reflect adverse conditions for patients with melanoma, breast, cervical, prostate, gastric, or pancreatic cancer [22]. The gene discussed is CCL5; the disease is melanoma.